Join us for a live webinar where expert faculty will provide actionable insights on improving patient identification and engagement for CAR T-cell therapy in diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL).

Join us for a live, interactive TheraTalk session with an expert panel of nationally recognized lipid specialists as they review the latest guideline recommendations, pivotal evidence, and evolving strategies for LDL-C management.

Platinum-resistant ovarian cancer (PROC) remains one of the most significant challenges in gynecologic oncology; however, novel antibody-drug conjugates (ADCs) and innovative investigational therapies are opening new avenues to improve outcomes.

Novel targeted therapies offer new hope to slow progression and improve quality of life in meaningful ways for patients with primary biliary cholangitis (PBC).

Join us for a live webinar focused on the evolving role of immunotherapy in early-stage resectable non-small cell lung cancer (NSCLC).

Post-COVID conditions (PCC) refer to a diverse array of symptoms that persist for weeks, months, and even years after acute SARS-CoV-2 infection and significantly impact quality of life.

Longstanding barriers to care combined with an elevated risk of diabetic macular edema (DME) contribute to the disproportionate burden of DME in Native American communities.

Bipolar disorder (BD) is a chronic and disabling mood disorder often complicated by overlapping symptoms, frequent misdiagnosis, poor adherence, and comorbidities, leaving significant gaps in care.

Enhance your expertise in MASH diagnosis and management with this preceptorship. Join us for a two-part training experience that will elevate your skills and connect you with liver-focused professionals. Part I is virtual; Part II is in-clinic.

Join us for a live, expert-led webinar exploring the evolving role of GPRC5D-targeted CAR T-cell therapies in multiple myeloma.